News
06-01-2010, 11:25 PM
TapImmune Inc. announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical development of a breast cancer vaccine technology. The option to license this technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune.
More... (http://www.news-medical.net/news/20100602/TapImmune-signs-Licensing-Option-agreement-with-Mayo-Clinic-for-breast-cancer-vaccine-technology.aspx)
More... (http://www.news-medical.net/news/20100602/TapImmune-signs-Licensing-Option-agreement-with-Mayo-Clinic-for-breast-cancer-vaccine-technology.aspx)